Impurity C of AlfacalcidolCAS# 82266-85-1 |
2D Structure
- GS-9620
Catalog No.:BCC1602
CAS No.:1228585-88-3
- Anguizole
Catalog No.:BCC1365
CAS No.:442666-98-0
- Vidarabine
Catalog No.:BCC4877
CAS No.:5536-17-4
- Amantadine HCl
Catalog No.:BCC4465
CAS No.:665-66-7
- Arctigenin
Catalog No.:BCN6291
CAS No.:7770-78-7
- Imiquimod hydrochloride
Catalog No.:BCC4196
CAS No.:99011-78-6
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 82266-85-1 | SDF | Download SDF |
PubChem ID | 71576655 | Appearance | Powder |
Formula | C35H49N3O4 | M.Wt | 575.78 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in DMSO | ||
Chemical Name | (10R,13R,14R)-7-[(3S,5R)-3,5-dihydroxy-2-methylcyclohexen-1-yl]-14-methyl-13-[(2R)-6-methylheptan-2-yl]-4-phenyl-2,4,6-triazatetracyclo[7.7.0.02,6.010,14]hexadec-8-ene-3,5-dione | ||
SMILES | CC1=C(CC(CC1O)O)C2C=C3C4CCC(C4(CCC3N5N2C(=O)N(C5=O)C6=CC=CC=C6)C)C(C)CCCC(C)C | ||
Standard InChIKey | PTIHYNIKYFVMFI-UURGVQEHSA-N | ||
Standard InChI | InChI=1S/C35H49N3O4/c1-21(2)10-9-11-22(3)28-14-15-29-27-20-31(26-18-25(39)19-32(40)23(26)4)38-34(42)36(24-12-7-6-8-13-24)33(41)37(38)30(27)16-17-35(28,29)5/h6-8,12-13,20-22,25,28-32,39-40H,9-11,14-19H2,1-5H3/t22-,25-,28-,29+,30?,31?,32+,35-/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Impurity C of Alfacalcidol Dilution Calculator
Impurity C of Alfacalcidol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 1.7368 mL | 8.6839 mL | 17.3677 mL | 34.7355 mL | 43.4194 mL |
5 mM | 0.3474 mL | 1.7368 mL | 3.4735 mL | 6.9471 mL | 8.6839 mL |
10 mM | 0.1737 mL | 0.8684 mL | 1.7368 mL | 3.4735 mL | 4.3419 mL |
50 mM | 0.0347 mL | 0.1737 mL | 0.3474 mL | 0.6947 mL | 0.8684 mL |
100 mM | 0.0174 mL | 0.0868 mL | 0.1737 mL | 0.3474 mL | 0.4342 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Impurity of Alfacalcidol. Alfacalcidol (1-hydroxycholecalciferol; Alpha D3; 1.alpha.-Hydroxyvitamin D3) is a non-selective VDR activator medication. IC50 value: Target: VDR activator Alfacalcidol (1-hydroxycholecalciferol; Alpha D3; 1.alpha.-Hydroxyvitamin D3) improves mechanical bone strength and bone mass; suppresses osteoclastic bone resorption in vivo.
References:
[1]. Shiraishi et al (2000) Alfacalcidol inhibits bone resorption and stmulates formation in an ovariectomized rat model of osteoporosis: Distinct actions from estrogen. Journal of Bone and Mineral Research. 15 770.
[2]. Ringe JD, Schacht E. et al. Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol. Rheumatol Int. 2004 Jul;24(4):189-97.
[3]. Ivarsen P, Povlsen JV, Christensen KL.Effect of alfacalcidol on cardiac function in patients with chronic kidney disease stage 4 and secondary hyperparathyroidism: A pilot study.Scand J Urol Nephrol. 2012 Jun 25.
[4]. Rianthavorn P, Pisutikul K, Deekajorndech T, Tepmongkol S, Suphapeetiporn K.Prevention of bone loss in children receiving long-term glucocorticoids with calcium and alfacalcidol or menatetrenone.J Pediatr Endocrinol Metab. 2012;25(3-4):307-12.
- Atomoxetine HCl
Catalog No.:BCC5046
CAS No.:82248-59-7
- Andrographiside
Catalog No.:BCN4569
CAS No.:82209-76-5
- Andropanoside
Catalog No.:BCN4570
CAS No.:82209-72-1
- FMK
Catalog No.:BCC1580
CAS No.:821794-92-7
- CMK
Catalog No.:BCC1489
CAS No.:821794-90-5
- JNJ 17203212
Catalog No.:BCC7668
CAS No.:821768-06-3
- NSC 33994
Catalog No.:BCC2441
CAS No.:82058-16-0
- Loteprednol etabonate
Catalog No.:BCC4916
CAS No.:82034-46-6
- Boc-Leucinol
Catalog No.:BCC2724
CAS No.:82010-31-9
- 10Z-Hymenialdisine
Catalog No.:BCC5773
CAS No.:82005-12-7
- Daurichromenic acid
Catalog No.:BCN4355
CAS No.:82003-90-5
- 8-Anilino-1-naphthalenesulfonic acid
Catalog No.:BCC8785
CAS No.:82-76-8
- Breyniaionoside A
Catalog No.:BCN7112
CAS No.:823182-23-6
- Styraxlignolide F
Catalog No.:BCN3416
CAS No.:823214-06-8
- SN 2
Catalog No.:BCC6325
CAS No.:823218-99-1
- Coelonin
Catalog No.:BCN3600
CAS No.:82344-82-9
- Heliocoromandaline
Catalog No.:BCN2046
CAS No.:82354-33-4
- Heliocurassavicine
Catalog No.:BCN2049
CAS No.:82354-34-5
- Humantenmine
Catalog No.:BCN4357
CAS No.:82354-38-9
- 2,3,5,4'-Tetrahydroxyl diphenylethylene-2-O-glucoside
Catalog No.:BCN1340
CAS No.:82373-94-2
- Heliocurassavinine
Catalog No.:BCN2050
CAS No.:82374-02-5
- Humantenine
Catalog No.:BCN4358
CAS No.:82375-29-9
- Humantenirine
Catalog No.:BCN4850
CAS No.:82375-30-2
- Ganciclovir
Catalog No.:BCC4908
CAS No.:82410-32-0